Form 4 holding
Officer Title: Chief Financial Officer and Treasurer
Aerovate Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 28,763
- Estimated value
- $470,850
- Report date
- 14 Jun 2024
- Price
- $16.37
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount